We sponsored the CleanUP IPF trial

The CleanUP IPF trial is the first pragmatic trial and the largest single, NHLBI sponsored IPF trial.

Once completed, researchers will utilize new technologies and

platforms to analyze the collected data and biological samples.

Participating Medical Centers

Alabama

University of Alabama at Birmingham

Arizona

University of Arizona-Tucson

California

University of California – Davis

Stanford Medical Center

Illinois

Loyola University Chicago

Northwestern Memorial Hospital

University of Chicago Medical Center

Massachusetts

Massachusetts General Hospital

Brigham & Women’s Hospital

Beth Israel Deaconess Medical Center

Michigan

Spectrum Health Pulmonary

University of Michigan

Minnesota

Mayo Clinic

University of Minnesota

New Hampshire

Dartmouth-Hitchcock Medical Center

New York

Albany Medical College

Columbia University

University of Rochester Medical Center

Weill Cornell Medicine

Ohio

University of Cincinnati Medical Center

Cleveland Clinic

OSU Wexner Medical Center

Pennsylvania

Penn State Hershey Medical Center

Temple University

Tennessee

Vanderbilt University

Texas

University of Texas Health Science Center San Antonio

Utah

University of Utah Health Sciences – Lung Health Clinical Research

Virginia

UVA Medical Center

INOVA

Washington

University of Washington Medical Center

The Cleanup IPF trial is possible thanks to the leadership and foresight of the investigators and the financial support of the National Heart, Lung, and Blood Institute (NHLBI), Three Lakes Partners, Veracyte and our IPF Foundation.

“If micro-organisms are triggering and/or sustaining the disease and we are able to figure this out, then a cure should be in sight.”

– Dr. Jerry Eu, Former Program Director, Immunology/Fibrosis at the NIH (2016)

The CleanUP IPF Trial is Curve Jumping!

Add your name to join the community working to end idiopathic pulmonary fibrosis.